Literature DB >> 2702430

The cost of bilateral orchiectomy as a treatment for prostatic carcinoma.

S McClinton1, L E Moffat, A Ludbrook.   

Abstract

Advanced prostatic carcinoma may be treated by a variety of methods of hormonal manipulation which affect the production of the male hormones. This can be achieved by surgical means, usually bilateral orchiectomy, or medically, by a number of drugs. One advantage of surgical over medical castration is that it is a once-only procedure. Another factor, which could be considered a major advantage, is the low cost of the surgical procedure. This report outlines the costs involved in treating prostatic carcinoma by surgical castration and compares them with the costs of some forms of medical treatment.

Entities:  

Mesh:

Year:  1989        PMID: 2702430     DOI: 10.1111/j.1464-410x.1989.tb05195.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  6 in total

1.  Medical or surgical orchidectomy: the patients' choice.

Authors:  D J Chadwick; D A Gillatt; J C Gingell
Journal:  BMJ       Date:  1991-03-09

Review 2.  Periodic health examination, 1991 update: 3. Secondary prevention of prostate cancer. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-09-01       Impact factor: 8.262

Review 3.  Comparison of the cost-effectiveness of various therapies for common prostatic disorders.

Authors:  E A Amin; M Amin
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

Review 4.  Clinical and economic considerations in the treatment of prostate cancer.

Authors:  E Varenhorst; P Carlsson; K Pedersen
Journal:  Pharmacoeconomics       Date:  1994-08       Impact factor: 4.981

5.  Simultaneous vs sequential bilateral cataract surgery for infants with congenital cataracts: Visual outcomes, adverse events, and economic costs.

Authors:  Hreem Dave; Vidya Phoenix; Edmund R Becker; Scott R Lambert
Journal:  Arch Ophthalmol       Date:  2010-08

6.  Subcapsular orchiectomy in the primary therapy of patients with bone metastasis in advanced prostate cancer: an anachronistic intervention?

Authors:  Oleg Rud; Julia Peter; Reza Kheyri; Christian Gilfrich; Ali M Ahmed; Wieland Boeckmann; Paul G Fabricius; Matthias May
Journal:  Adv Urol       Date:  2011-09-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.